At a glance
- Originator Schering-Plough
- Class Antidementias; Antiepileptic drugs; Neuroprotectants
- Mechanism of Action GABA B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Absence epilepsy; Cognition disorders
Most Recent Events
- 15 Jun 2004 Discontinued - Preclinical for Absence seizures in USA (unspecified route)
- 15 Jun 2004 Discontinued for Cognition disorders in USA (unspecified route)
- 25 Aug 1998 No-Development-Reported for Absence seizures in USA (Unknown route)